As of Nov 25
| +0.55 / +1.86%|
The 7 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 54.00, with a high estimate of 56.00 and a low estimate of 47.00. The median estimate represents a +79.70% increase from the last price of 30.05.
The current consensus among 7 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.